◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›GSK

GSK (GSK)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

Zacks·vor 1 Tagen

GSK's Jemperli Delivers Promising Interim Data in Rectal Cancer

Proactive·vor 1 Tagen

UBS keeps GSK at 'neutral' with focus on chief executive's strategy update

GlobeNewswire·vor 5 Tagen

Connective Tissue Disease Associated with Interstitial Lung Disease Market Report, Details Drug Class Breakdown Across Corticosteroids, Antifibrotics, Immunosuppressants, and Biologics

PR Newswire·vor 5 Tagen

Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight

MT Newswires·vor 6 Tagen

Sector Update: Healthcare Stocks Lean Lower Pre-Bell Wednesday

The Wall Street Journal·vor 7 Tagen

Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership

Frag BlackSpecter AI über GSK

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist GSK kaufenswert?GSK Earnings Analyse GSK Bewertung

AI Chat öffnen →